M. Taal

First name
M.
Middle name
W.
Last name
Taal
Nakafero, G., Grainge, M. J., Card, T., Mallen, C. D., Riley, R., van der Windt, D., et al. (2022). Incidence and pattern of mycophenolate discontinuation associated with abnormal monitoring blood-test results: cohort study using data from the Clinical Practice Research Datalink Aurum. Rheumatol Adv Pract, 6, rkac046. http://doi.org/10.1093/rap/rkac046
Nakafero, G., Grainge, M. J., Card, T., Mallen, C. D., Zhang, W., Doherty, M., et al. (2021). What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keab254
Nakafero, G., Grainge, M. J., Card, T., Taal, M. W., Aithal, G. P., Zhang, W., et al. (2021). Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood-tests during long-term treatment: cohort study using data from Clinical Practice Research Datalink Gold and Aurum. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keab790